TSHATaysha Gene Therapies, Inc.vs its industry peers
A metric-by-metric comparison of Taysha Gene Therapies, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TSHAEsta | $1.7B#8 | — | 4.3x#6 | 169.0x#9 | 17.3%#7 | -22.1%#6 | -1130.6%#9 | -28.1%#5 | — | — | 79.2%#3 | — |
| BCRX | $2.2B#1 | — | — | 2.5x#2 | 94.1%#3 | 396.9%#1 | 39.0%#2 | — | — | — | — | — |
| KOD | $2.1B#2 | — | 33.7x#10 | — | — | -30.5%#9 | — | -376.4%#10 | — | — | — | — |
| VCEL | $2.1B#3 | 83.7x#4 | 5.6x#8 | 7.5x#4 | 16.5%#8 | 59.4%#3 | 4.0%#4 | 4.5%#2 | 4.0%#2 | 7#1 | — | — |
| ADMA | $2.0B#4 | 12.7x#2 | 4.9x#7 | 3.9x#3 | 19.6%#6 | -25.7%#7 | 37.5%#3 | 36.0%#1 | 32.9%#1 | 5#2 | — | — |
| COAG | $1.9B#5 | — | 4.2x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| VIR | $1.8B#6 | — | 1.8x#1 | 26.0x#8 | -7.6%#9 | 16.1%#5 | -699.2%#7 | -44.6%#7 | — | — | — | — |
| RXRX | $1.7B#7 | — | 1.9x#2 | 22.8x#7 | 26.9%#5 | -39.1%#10 | -867.9%#8 | -70.5%#8 | -175.2%#4 | — | — | — |
| NVAX | $1.5B#9 | — | — | 1.4x#1 | 64.7%#4 | 334.8%#2 | 40.3%#1 | — | — | — | 9.3%#4 | — |
| INBX | $1.5B#10 | — | — | 1149.6x#10 | 550.0%#1 | -108.3%#11 | -10386.5%#10 | — | — | — | 282.3%#1 | — |
| MAZE | $1.3B#11 | — | 2.9x#4 | 7.9x#5 | — | -351.0%#12 | -85.3%#5 | -28.9%#6 | -49.4%#3 | — | 1.8%#5 | — |
| VOR | $1.3B#12 | 0.1x#1 | — | — | — | -495.3%#13 | — | — | — | — | — | — |
| MGTX | $1.2B#13 | 14.6x#3 | — | 15.0x#6 | 144.6%#2 | 22.7%#4 | -130.2%#6 | — | — | — | — | — |
| ODTX | $1.1B#15 | — | 2.6x#3 | — | — | — | — | 0.0%#3 | — | — | — | — |
| REPL | $1.2B#14 | — | 11.6x#9 | — | — | -26.9%#8 | — | -297.1%#9 | -7270.9%#5 | — | 124.3%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice